With the share price as a guide, I was anticipating some negative news about fee indexation in Australia or the reintroduction of a fee freeze in the US.
There also at least a portion of the share price decline attributable to the rise in interest rate expectations this year. US 10 year going ~3.8% to ~4.5% this year. Their business model is buying pathology businesses with debt.
Regardless, I did buy a few more today.
With the share price as a guide, I was anticipating some...
-
- There are more pages in this discussion • 20 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add SHL (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$27.65 |
Change
0.410(1.51%) |
Mkt cap ! $13.25B | |||
| Open | High | Low | Value | Volume |
| $27.40 | $27.69 | $27.34 | $7.492M | 271.5K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 10 | 348 | $27.64 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $27.65 | 168 | 6 |
View Market Depth
| Last trade - 15.10pm 15/10/2024 (20 minute delay) ? |
| SHL (ASX) Chart |